HAO

Haoxi Health Technology Ltd

2.12

Oct 23 • 3:42 PM ET -0.02 (-0.93%)

2.01

Aftermarket • 6:28 PM ET -0.11 (-5.11%)

Communication Services Advertising Agencies China Nano NASD

Peers: BAOS CNET CHR VSME STFS KRKR MF WIMI IZEA DLPN

Scroll to Statements

Index	-
Market Cap	1.30M
Enterprise Value	-8.02M
Income	-9.54M
Sales	54.83M
Book/sh	3214.28
Cash/sh	17.82
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	28
IPO	Jan 26, 2024

P/E	-
Forward P/E	-
PEG	-
P/S	0.02
P/B	0.00
P/C	0.12
P/FCF	-
EV/EBITDA	-
EV/Sales	-0.15
Quick Ratio	4.53
Current Ratio	4.53
Debt/Eq	0.09
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-4403.15
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	24.77% 33.67%
EPS Y/Y TTM	-270.67%
Sales Y/Y TTM	67.14%
EPS Q/Q	-113.16%
Sales Q/Q	137.31%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	2.61%
Insider Trans	-
Inst Own	0.49%
Inst Trans	3.10%
ROA	-44.18%
ROE	-54.13%
ROIC	-53.40%
Gross Margin	1.15%
Oper. Margin	-14.88%
Profit Margin	-17.39%
SMA20	-11.49%
SMA50	-26.64%
SMA200	-99.83%
Trades

Shs Outstand	0.61M
Shs Float	0.60M
Short Float	4.10%
Short Ratio	0.12
Short Interest	0.02M
52W High	4352.00 -99.95%
52W Low	1.95 8.72%
Volatility	9.20% 7.15%
ATR (14)	0.32
RSI (14)	29.63
Beta	-1.06
Rel Volume	0.08
Avg Volume	202.38K
Volume	16,200

Perf Week	0.47%
Perf Month	-28.62%
Perf Quarter	-38.41%
Perf Half Y	-99.93%
Perf YTD	-99.92%
Perf Year	-99.93%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	2.14
Price	2.12
Change %	-0.93%

Aug-12-26 08:00AM	Haoxi Health Technology Limited Announces 1-For-20 Reverse Share Split (GlobeNewswire)
Jul-14-26 10:44AM	Haoxi Health Technology Signs Strategic Cooperation to Develop AI Digital Marketing System (InvestorsHub) +7.34%
06:30AM	Haoxi Health Technology Limited Announces Strategic Cooperation Framework with NOVA MEDIA to Develop An AI Digital Marketing System (GlobeNewswire)
Jul-10-26 01:15PM	Haoxi Health Technology Ltd Announces $4 Million Registered Direct Offering (GlobeNewswire) -66.48%
May-19-26 08:30AM	Haoxi Health Technology Limited Announces 1-For-128 Reverse Share Split (GlobeNewswire) -21.35%
10:30AM	Loading…
May-18-26 10:30AM	BC-Most Active Stocks (Associated Press) -20.89%
May-15-26 10:30AM	BC-Most Active Stocks (Associated Press) -14.45%
May-14-26 10:30AM	BC-Most Active Stocks (Associated Press) -23.77%
May-13-26 10:30AM	BC-Most Active Stocks (Associated Press) -15.23%
May-12-26 10:30AM	BC-Most Active Stocks (Associated Press) -9.56%
May-11-26 11:00AM	Registered Direct Offering Raises Dilution Questions for Haoxi Health Technology (InvestorsHub) -93.84%
10:30AM	BC-Most Active Stocks (Associated Press)
08:00AM	Haoxi Health Technology Ltd Announces $6.5 Million Registered Direct Offering (GlobeNewswire)
Mar-03-26 07:30AM	HAOXI HEALTH TECHNOLOGY and Eaglepoint AI Forge Strategic Partnership to Enter AI-Powered Health Management Track (GlobeNewswire) -13.62%
Apr-21-25 09:45AM	Haoxi Health Technology Limited Launches Customized Livestreaming Agency Strategy (GlobeNewswire) -5.13%
08:30AM	Loading…
Feb-11-25 08:30AM	Haoxi Health Technology Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule (GlobeNewswire) -5.67%
Jan-23-25 08:30AM	Haoxi Health Technology Limited Announces 1-for-25 Reverse Share Split (GlobeNewswire) -22.44%
Nov-27-24 09:25AM	Haoxi Health Technology Limited Awarded a RMB30 Milllion Framework Contract to Provide Digital Advertising Services for Tengyuan Media Advertising Co., Ltd. (GlobeNewswire) -36.59%
Nov-06-24 04:05PM	Haoxi Health Technology Limited Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency (GlobeNewswire) -7.85% +12.97%
Oct-29-24 08:30AM	Haoxi Health Technology Limited Reports Financial Results for Fiscal Year Ended June 30, 2024 (GlobeNewswire)
Oct-08-24 08:46AM	Haoxi Health Technology sees FY24 revenue $48.52M vs. $28.23M last year (TipRanks) -17.10%
Oct-07-24 08:00AM	Haoxi Health Technology Limited Announces Preliminary Unaudited FY24 Financial Results with projected 72% Revenue Growth (GlobeNewswire) -25.38%
Sep-25-24 09:00AM	Haoxi Health Technology Limited and Global Mofy AI Ltd Announce Strategic Partnership to Innovate AI Marketing Solutions (GlobeNewswire) +11.28%
Sep-20-24 04:05PM	Haoxi Health Technology Limited Announces the Closing of a $12 Million Underwritten Follow-on Public Offering (GlobeNewswire) -27.50% -17.24%
Sep-19-24 09:25AM	Haoxi Health Technology Limited Announces Pricing of a $12 Million Underwritten Follow-on Public Offering (GlobeNewswire) -73.33%
Jun-09-24 08:00PM	Haoxi Health Technology Limited Facilitates International Humanitarian Aid Efforts Amid Global Challenges (Business Wire)
May-31-24 08:00AM	Haoxi Health Technology Limited Reports Unaudited Financial Results for The Six Months Ended December 31, 2023 (GlobeNewswire) -8.92%
May-07-24 08:00AM	Haoxi Health Technology Limited Enters into Rebate Agreement with Clients on Advertising Placement Campaign (GlobeNewswire)
May-03-24 08:00AM	Haoxi Health Technology Limited Enters into Advertising Placement Service Framework Contract (GlobeNewswire)
Jan-30-24 04:05PM	Haoxi Health Technology Limited Announces Closing of $9,600,000 Initial Public Offering (GlobeNewswire) +62.39%
04:31PM	Loading…
Jan-25-24 04:31PM	Haoxi Health Technology Limited Announces Pricing of Its Initial Public Offering (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fan Zhen	CEO & Chairman	May 19 '26	Buy	0.02	40,000,000	720,000	40,690,800	May 20 04:15 PM

Haoxi Health Technology Ltd. is a holding company, which engages in the provision of online marketing solutions. It produces online ads for advertisers to acquire, convert, and retain consumers on various media platforms. The company was founded on September 26, 2018 and is headquartered in Beijing, China.

Chairman & CEOMr. Zhen Fan

FounderMr. Lei Xu

Chief Financial OfficerMs. Dongxue Li

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HAO

Haoxi Health Technology Ltd

Upgrade your Finviz experience